FACILE THERAPEUTICS
Facile Therapeutics is a biotechnology company that develops therapeutic drugs for clostridium difficile infection. The company demonstrated Ebselen, an anti-toxin that doesn't cause the death of healthy gut bacteria that makes the colon resistant to C diff reinfection. Facile Therapeutics was founded in 2017 by Marc Navre and Matthew Bogyo and is based in Belmont, California.
FACILE THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
2017-01-01
Address:
Belmont, California, United States
Country:
United States
Website Url:
http://www.faciletx.com
Total Employee:
1+
Status:
Active
Total Funding:
1.26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Magenta Therapeutics
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Founder
Investors List
CARB-X
CARB-X investment in Grant - Facile Therapeutics
SkyDeck Berkeley
SkyDeck Berkeley investment in Non Equity Assistance - Facile Therapeutics
